Please login to the form below

Not currently logged in

STEM Healthcare founder Rob Wood secures a 25% stake in performance-io

performance-io launched three years ago as pharma’s first ‘performance marketing’ agency

performance-io, a London-based online performance marketing agency for pharma, has announced a new multi-million-pound deal with STEM founder Rob Wood (pictured above).

As part of the deal, performance-io has sold a 25% stake in the business to Wood. The agency was launched three years ago by Matt Lowe as the first ‘performance marketing’ firm dedicated to the pharma sector.

performance-io uses audience behaviour data to define ‘optimal online ecosystems’ for brands before they are built, and then optimise and improve their subsequent campaigns.

Since its launch, the agency now operates in 18 countries, with a number of leading global pharma companies now using its services, including the likes of Bayer, Novo Nordisk and Boehringer Ingelheim.

“This past year we’ve seen a number of companies approach us to develop strategies and manage execution of SEO and SEO content, moving away from large integrated agencies that ‘do everything’ in order to engage more customers,” said Lowe (pictured left).

“Bringing in Rob’s experience in building the industry’s leading benchmarking product partnered with our digital benchmarking and progressive disciplines in SEO, will help us to accelerate our solutions to an even broader audience and continue to drive a competitive advantage for our clients,” he added.

Wood, who previously worked as a director at pharma company AstraZeneca, founded and sold commercial, marketing and medical audit firm STEM to UDG Healthcare in 2016 in a deal worth £84m.

STEM’s service offerings include quantifying and benchmarking companies' organisational alignment and quality of execution, to create action plans for accelerating brand performance.

Lowe will continue as chief executive officer of performance-io, while Wood will join the executive board.

Article by
Lucy Parsons

12th February 2021

From: Marketing



COVID-19 Updates and Daily News

Featured jobs


Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, healthcare communication services to the pharmaceutical industry across the globe, with a focus...

Latest intelligence

Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....
COVID-proof: How Teams are Creating Launch Intensity thru Adversity
Now that the game has changed, how are marketers shifting their launch behaviour? We've identified 5 common observations from effective teams....
5 ways that lockdowns and restrictions could be affecting our allergies
Over this last year, lockdowns and restrictions have led to changes in the day-to-day environments for people across the world. For Allergy Awareness week, we wanted to explore some of...